Related Experiment Video
Updated: Jun 17, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Long-term effectiveness of lumboperitoneal flow-regulated shunt system for idiopathic intracranial hypertension
S Ulivieri1, G Oliveri, M Georgantzinou
1Department of Neurosurgery, Santa Maria alle Scotte Hospital, Siena, Italy. simone.ulivieri@emailit
Insights
Lumboperitoneal shunts with flow-regulated valves effectively treated idiopathic intracranial hypertension (IIH) in four patients. This surgical therapy successfully alleviated symptoms without requiring revisions.
Area of Science:
- Neurosurgery
- Neurology
Background:
- Idiopathic intracranial hypertension (IIH) presents a significant neurological challenge.
- Surgical intervention is sometimes necessary for refractory IIH cases.
Purpose of the Study:
- To evaluate the efficacy of lumboperitoneal shunts with flow-regulated valves for treating idiopathic intracranial hypertension (IIH).
Main Methods:
- Retrospective analysis of four patients diagnosed with IIH.
- Treatment involved the implantation of lumboperitoneal flow-regulated shunts (OSV II Smart Valve Systems).
- Mean follow-up duration was 13 months.
Main Results:
- All patients experienced successful symptom alleviation following shunt placement.
- No instances of shunt revision were required in the study cohort.
- Flow-regulated valves demonstrated effective management of IIH.
Conclusions:
- Lumboperitoneal shunts with flow-regulated valves represent a satisfactory surgical treatment option for select IIH patients.
- This approach offers a viable solution for managing IIH when conservative measures fail.
Aim:
The aim of the study was to assess the efficacy of lumboperitoneal flow-regulated shunt for the treatment of idiopathic intracranial hypertension (IIH).
Methods:
This was a retrospective study carried out on four patients with IIH, treated from January to December 2007 with lumboperitoneal flow-regulated shunt (OSV II Smart Valve Systems; Integra NeuroSciences). The mean follow-up period was 13 months.
Results:
The treatment was successful in alleviating symptoms in all cases and no patient required revisions.
Conclusions:
In conclusion the placement of flow-regulated valves is a satisfactory treatment for those IIH patients who require surgical therapy.
